Martingale Asset Management »

Janux Therapeutics shares owned by Martingale Asset Management

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $155k 11k 13.80

More positions owned by Martingale Asset Management

Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Cisco Systems (CSCO)
Facebook Inc cl a (META)
Berkshire Hathaway (BRK.B)
Visa (V)
Exxon Mobil Corporation (XOM)
Wal-Mart Stores (WMT)
NVIDIA Corporation (NVDA)
MasterCard Incorporated (MA)

View all positions for Martingale Asset Management

Top funds holding Janux Therapeutics

RA Capital Management
FMR
Henderson Group
BlackRock
State Street Corporation
Vanguard Group
Adage Capital Partners GP
Prosight Management
OrbiMed Advisors
TCG Crossover Management
Alyeska Investment Group
Geode Capital Management
Goldman Sachs Group
Woodline Partners
Logos Global Management

View all funds holding Janux Therapeutics